Similar articles

• Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.

  Lamanna C, Monami M, Marchionni N, Mannucci E. Lamanna C, et al. Diabetes Obes Metab. 2011 Mar;13(3):221-8. doi: 10.1111/j.1463-1326.2010.01349.x. Diabetes Obes Metab. 2011. PMID: 21205121
• Intensive glucose lowering treatment in type 2 diabetes.

  Preiss D, Ray KK. Preiss D, et al. BMJ. 2011 Jul 26;343:d4243. doi: 10.1136/bmj.d4243. BMJ. 2011. PMID: 21791496 No abstract available.
• Interplay of diabetes and coronary heart disease on cardiovascular mortality.

  Boccara F, Cohen A. Boccara F, et al. Heart. 2004 Dec;90(12):1371-3. doi: 10.1136/hrt.2004.035766. Heart. 2004. PMID: 15547003 Free PMC article.
• Does lowering of blood glucose improve cardiovascular morbidity and mortality?

  Iqbal N, Rubenstein AH. Iqbal N, et al. Clin J Am Soc Nephrol. 2008 Jan;3(1):163-7. doi: 10.2215/CJN.05041107. Clin J Am Soc Nephrol. 2008. PMID: 18178783 Review. No abstract available.
• Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR.

  Bell DS. Bell DS. Postgrad Med. 2012 Sep;124(5):121-35. doi: 10.3810/pgm.2012.09.2598. Postgrad Med. 2012. PMID: 23095432 Review.